Skip to content

NovoCure NVCR Interest Expense

Interest Expense at other companies

Boston Scientific logo
Boston ScientificBSX
$90M+9.8%
Medtronic logo
MedtronicMDT
$176M+1.1%
Nuvation Bio logo
Nuvation BioNUVB
$6.71M+12,322%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
$0-100%
ALN
Alnylam PharmaceuticalsALNY
$69.29M+18.8%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$12.94M-28.6%

Other financials

Income statement

See full
Revenue$174.1M+12.3%
Gross profit$135.1M+16.0%
Operating income-$67.4M-78.1%
Net income-$71.1M-107%
EPS (diluted)-$0.62-100%

Balance sheet

See full
Cash & equivalents$87.5M-31.2%
Total debt$39.5M-2.1%
Total equity$330.7M-8.6%
Total assets$787.9M-36.9%

Cash flow

See full
Operating cash flow-$13.5M+62.1%
CapEx$5.2M-51.4%
Free cash flow-$18.7M+59.7%

Valuation

See full
Market cap$1.7B-36.7%
Enterprise value$1.66B-36.3%
P/S2.5×-1.8×

Profitability

See full
Gross margin75.2%-2.0pp
Operating margin-27.2%+0.4pp
Net margin-25.7%-0.7pp
FCF margin-7.1%-2.0pp

Returns & leverage

See full
Return on equity-50%+5.4pp
Debt / equity0.1×0.0×
Current ratio2.9×+1.4×

Where this comes from

Reported directly by NovoCure in its filing.

Tagged under the XBRL concept us-gaap:InterestIncomeExpenseNonoperatingNet.

The official record: NovoCure’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about NovoCure's interest expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is NovoCure's interest expense?
NovoCure (NVCR) reported interest expense of -$1.84M in Q1 2026.
How has NovoCure's interest expense changed year-over-year?
NovoCure's interest expense decreased by 124.3% year-over-year, from $7.57M to -$1.84M.
What is the long-term trend for NovoCure's interest expense?
Over 4 years (2021 to 2025), NovoCure's interest expense has grown at a 137.4% compound annual growth rate (CAGR), from -$570K to $18.11M.
What does interest expense mean?
Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.